Results for tag: "Refractory Angina Drug"

Refractory Angina is a type of chest pain caused by reduced blood flow to the heart. It is a form of cardiovascular disease and is treated with drugs that reduce the symptoms of angina. These drugs are known as anti-anginal drugs and are used to reduce the frequency and severity of angina attacks. Commonly used anti-anginal drugs include nitrates, calcium channel blockers, beta-blockers, and ranolazine. Nitrates are used to relax the blood vessels and reduce the workload on the heart, while calcium channel blockers and beta-blockers reduce the heart rate and blood pressure. Ranolazine is used to reduce the amount of oxygen needed by the heart muscle. The Refractory Angina Drug market is a subset of the larger Cardiovascular Drugs market. It is composed of pharmaceutical companies that develop and market drugs to treat refractory angina. These companies focus on developing new drugs and improving existing drugs to provide better treatment options for patients. Some of the companies in the Refractory Angina Drug market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more